C

Choong Ang Vaccine Laboratory
KOSDAQ:072020

Watchlist Manager
Choong Ang Vaccine Laboratory
KOSDAQ:072020
Watchlist
Price: 9 550 KRW 0.42% Market Closed
Market Cap: ₩92.3B

Balance Sheet

Balance Sheet Decomposition
Choong Ang Vaccine Laboratory

Balance Sheet
Choong Ang Vaccine Laboratory

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
86
757
572
460
712
2 210
2 710
2 574
13 875
1 371
1 666
1 965
2 328
7 413
8 793
14 470
9 952
10 986
13 398
12 281
11 337
7 848
14 389
13 463
Cash
0
0
0
0
0
0
0
0
935
0
0
0
7
4
1
3
1
2
1
2
3
4
3
2
Cash Equivalents
86
757
572
460
712
2 210
2 710
2 574
12 940
1 371
1 666
1 965
2 321
7 409
8 792
14 467
9 951
10 984
13 397
12 279
11 335
7 844
14 387
13 461
Short-Term Investments
129
240
4 040
1 740
1 902
1 589
6 890
9 815
778
12 315
14 813
9 244
6 307
3 647
5 098
5 621
5 069
17 300
10 927
10 486
10 131
10 138
13 035
15 690
Total Receivables
1 767
988
1 264
1 365
1 563
1 954
1 488
1 844
1 436
1 992
1 459
1 570
1 695
1 473
1 338
2 030
1 461
2 758
2 404
3 410
3 442
3 401
4 502
5 183
Accounts Receivables
1 760
988
1 237
1 334
1 518
1 868
1 456
1 715
1 217
1 508
1 240
1 256
1 689
1 472
1 336
2 030
1 445
2 551
2 341
2 271
3 383
3 300
4 345
5 037
Other Receivables
7
0
27
31
45
86
32
129
219
484
219
314
6
1
2
0
16
207
63
1 139
60
101
157
146
Inventory
1 473
1 654
2 089
2 433
2 616
2 598
2 387
3 363
3 549
3 656
4 503
6 303
13 037
14 035
13 257
14 027
16 676
16 145
15 471
15 923
14 613
17 918
18 464
17 690
Other Current Assets
28
15
205
230
455
99
211
144
260
219
251
189
202
180
212
211
209
140
149
241
320
284
171
424
Total Current Assets
3 482
3 653
8 170
6 228
7 247
8 451
13 687
17 740
19 899
19 553
22 692
19 271
23 569
26 747
28 698
36 359
33 366
47 329
42 350
42 342
39 844
39 590
50 561
52 450
PP&E Net
5 110
5 057
6 193
7 827
7 549
7 555
9 249
10 381
13 713
18 011
17 426
29 174
30 624
30 933
30 054
33 926
44 594
45 724
47 344
57 891
66 091
66 969
63 272
64 421
PP&E Gross
5 110
5 057
6 193
7 827
7 549
7 555
9 249
10 381
13 713
18 011
17 426
29 174
30 624
30 933
30 054
33 926
44 594
45 724
47 344
57 891
66 091
66 969
63 272
64 421
Accumulated Depreciation
2 656
3 033
3 504
4 039
4 649
5 278
4 712
5 307
5 976
6 553
7 916
9 461
12 396
15 052
18 474
21 281
23 464
27 156
28 328
31 636
30 123
35 759
40 722
45 796
Intangible Assets
97
49
153
274
388
527
564
926
1 171
1 244
1 112
824
1 130
1 292
1 285
1 069
951
998
774
446
325
439
533
1 064
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48
32
0
0
0
0
Long-Term Investments
299
299
334
332
325
600
1 667
1 392
510
550
413
623
593
573
890
1 075
1 365
865
4 720
3 403
4 036
4 411
2 976
3 672
Other Long-Term Assets
177
163
260
362
327
633
660
617
735
815
765
926
1 114
1 054
1 175
1 113
1 347
1 828
1 332
866
2 656
3 450
2 251
1 668
Total Assets
9 164
N/A
9 222
+1%
15 110
+64%
15 024
-1%
15 835
+5%
17 765
+12%
25 829
+45%
31 055
+20%
36 028
+16%
40 172
+12%
42 408
+6%
50 817
+20%
57 031
+12%
60 599
+6%
62 103
+2%
73 543
+18%
81 624
+11%
96 744
+19%
96 567
0%
104 979
+9%
112 952
+8%
114 859
+2%
119 593
+4%
123 275
+3%
Liabilities
Accounts Payable
152
11
549
423
388
213
453
578
506
1 017
182
189
1 536
1 197
2 436
1 913
965
668
526
443
607
443
307
793
Accrued Liabilities
230
174
166
257
183
250
524
564
990
429
658
535
901
958
1 643
1 498
1 374
1 694
1 630
2 834
2 307
2 199
3 289
3 581
Short-Term Debt
500
0
0
0
100
0
0
0
135
123
175
159
0
3 100
400
3 091
3 100
3 000
1 650
5 407
6 429
6 429
4 095
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
1 000
2 649
0
0
0
0
0
162
122
121
141
159
1 852
Other Current Liabilities
1 086
779
510
342
325
743
66
509
127
207
915
2 922
2 754
2 332
2 017
2 627
5 759
3 491
3 390
3 648
4 897
4 101
4 803
5 786
Total Current Liabilities
1 968
964
1 225
1 022
996
1 205
1 043
1 651
1 759
1 776
1 930
4 805
7 840
7 587
6 496
9 129
11 198
8 853
7 359
12 454
14 361
13 313
12 653
12 012
Long-Term Debt
1 534
953
975
372
519
78
0
0
0
0
0
1 500
500
400
0
3 500
5 400
2 400
2 512
4 732
5 340
5 975
6 820
7 026
Other Liabilities
304
334
258
248
368
338
236
406
289
218
395
391
568
622
727
548
349
486
329
244
275
267
316
370
Total Liabilities
3 805
N/A
2 251
-41%
2 457
+9%
1 641
-33%
1 882
+15%
1 621
-14%
1 279
-21%
2 057
+61%
2 048
0%
1 994
-3%
2 325
+17%
6 696
+188%
8 908
+33%
8 609
-3%
7 222
-16%
13 177
+82%
16 947
+29%
11 740
-31%
10 200
-13%
17 429
+71%
19 976
+15%
19 554
-2%
19 788
+1%
19 408
-2%
Equity
Common Stock
3 310
2 317
3 310
3 310
3 310
3 310
3 660
3 660
3 660
3 660
3 660
3 660
3 660
3 660
3 660
3 660
3 660
4 980
4 980
4 980
4 980
4 980
4 980
4 980
Retained Earnings
1 782
3 394
4 212
4 942
5 512
7 699
11 009
15 434
20 390
24 587
26 493
30 530
34 547
38 413
41 304
46 789
51 100
54 031
55 393
57 961
64 975
68 376
68 861
74 063
Additional Paid In Capital
267
1 260
5 131
5 131
5 131
5 131
9 916
9 916
9 916
9 916
9 916
9 916
9 916
9 916
9 916
9 916
9 916
26 022
26 023
26 023
26 023
26 023
26 023
26 023
Unrealized Security Profit/Loss
0
0
0
0
0
4
36
12
14
16
14
15
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
0
0
0
0
0
1 080
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
1 414
3 002
4 074
60
118
Total Equity
5 359
N/A
6 971
+30%
12 653
+82%
13 383
+6%
13 953
+4%
16 144
+16%
24 549
+52%
28 998
+18%
33 981
+17%
38 178
+12%
40 083
+5%
44 121
+10%
48 123
+9%
51 989
+8%
54 880
+6%
60 365
+10%
64 676
+7%
85 004
+31%
86 367
+2%
87 550
+1%
92 976
+6%
95 304
+3%
99 804
+5%
103 867
+4%
Total Liabilities & Equity
9 164
N/A
9 222
+1%
15 110
+64%
15 024
-1%
15 835
+5%
17 765
+12%
25 829
+45%
31 055
+20%
36 028
+16%
40 172
+12%
42 408
+6%
50 817
+20%
57 031
+12%
60 599
+6%
62 103
+2%
73 543
+18%
81 624
+11%
96 744
+19%
96 567
0%
104 979
+9%
112 952
+8%
114 859
+2%
119 593
+4%
123 275
+3%
Shares Outstanding
Common Shares Outstanding
5
6
8
8
8
8
9
9
9
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10